Antibody-Mediated Red Blood Cell Destruction: Agglutination and Hemolytic Anemia
When antibodies bind to antigens on red blood cells (RBCs), they cause agglutination (clumping) and can trigger hemolysis (RBC destruction), leading to hemolytic anemia.
Mechanism
- Antigen-antibody binding: IgG or IgM binds specific RBC surface antigens (ABO, Rh, Kell, Duffy, Kidd, etc.).
- Agglutination: IgM (pentamer) directly cross-links RBCs; IgG requires secondary mechanisms (complement, Fc receptor-mediated).
- Hemolysis pathways:
- Intravascular: Complement (C5b-9) membrane attack complex → RBC lysis in circulation → hemoglobinemia, hemoglobinuria.
- Extravascular: IgG-opsonized RBCs cleared by splenic/liver macrophages → bilirubin ↑, LDH ↑, haptoglobin ↓.
Types of Immune Hemolytic Anemia
Autoimmune Hemolytic Anemia (AIHA)
- Warm AIHA (IgG): Most common; idiopathic or secondary (SLE, CLL, drugs).
- Cold agglutinin disease (IgM): Cold-induced agglutination; complement-mediated.
- Paroxysmal cold hemoglobinuria (Donath-Landsteiner): Biphasic IgG.
Alloimmune
- Transfusion reaction (ABO mismatch — intravascular; delayed — extravascular).
- Hemolytic disease of fetus/newborn (Rh, Kell, etc.).
Drug-Induced
- Penicillin/cephalosporins (hapten mechanism).
- Methyldopa (autoantibody induction).
- Immune checkpoint inhibitors (emerging).
Infection-Associated
- Mycoplasma pneumoniae (cold agglutinins).
- EBV, CMV, HIV, hepatitis.
Clinical Features
- Anemia symptoms: fatigue, pallor, dyspnea, tachycardia.
- Hemolysis signs: jaundice, dark urine, splenomegaly.
- Acute: back pain, fever, hemoglobinuria (intravascular).
Diagnosis
- DAT (Direct Antiglobulin Test / Coombs): Detects IgG/C3 on RBCs.
- Reticulocytosis, ↑ LDH, ↑ indirect bilirubin, ↓ haptoglobin.
- Peripheral smear: spherocytes (warm AIHA), agglutinates (cold).
- Elution studies, antibody identification.
Treatment
- Stop offending drug/treat infection.
- Corticosteroids (1st line warm AIHA).
- Rituximab (anti-CD20).
- Splenectomy (refractory).
- Transfusion (if symptomatic; least incompatible).
- IVIG, complement inhibitors (sutimlimab for CAD).
Blood Disorders - Related Articles
- Understanding Sickle Cell Disease in Children: Causes & Management
- Antibody-Mediated Red Blood Cell Destruction: Agglutination and Hemolytic Anemia
- Leg Swelling and Blood Clots: Causes, Symptoms & Treatment
- Average Blood Volume in Women
- Blood Cell Lifespans: Red Cells, White Cells, and Platelets Production Timeline
- Betaloc CR Side Effects: What to Expect & Manage
- Blood Oxygen Levels: Normal Range and Clinical Context
